Abbott Extends Change-in-Control Agreements, Excludes CEO Robert B. Ford
Abbott extended change-in-control agreement terms for its named executive officers other than Chairman and CEO Robert B. Ford. Ford’s agreement expires at the end of 2026.
Abbott extended change-in-control agreement terms for its named executive officers other than Chairman and CEO Robert B. Ford. Ford’s agreement expires at the end of 2026.